Goldman-Backed Attovia Raises $289 Million in Top-Priced US IPO
Attovia Therapeutics, an early-stage biotech firm backed by Goldman Sachs, successfully raised $289 million in its US IPO, pricing at the top...

Attovia Therapeutics, an early-stage biotech firm backed by Goldman Sachs, successfully raised $289 million in its US IPO, pricing at the top...

Revolve Group forecasts Q3 2026 gross margins of 53.5%-54.0% and aims for double-digit revenue growth for the full year 2026, building on...

Soybean contracts saw significant declines on Tuesday, with nearbys falling up to 15 cents, driven by a wetter weather outlook and broader...

Pinterest's second quarter results reveal its AI-driven reinvention is paying off, with revenue exceeding $1 billion for the fourth consecutive quarter and...

TPG Inc. targets over $50 billion in capital raised by 2026, maintaining a 47% full-year FRE margin outlook. CEO Jon Winkelried cited...

Compania de Minas Buenaventura S.A. (BVN) shares crossed above their 200-day moving average on Tuesday, reaching $32.21 and closing up 5.7% on...

Cotton futures experienced a mixed close on Tuesday, August 4, 2026, with front-month contracts declining while other contracts posted gains. This divergence...

HSBC Holdings reported a robust first-half 2026 performance, driven by rising net interest income and double-digit top-line growth, alongside a $1 billion...

John Hancock Preferred Income Fund III (HPS) has declared a $0.11 monthly dividend, offering a 9.26% forward yield. The payout is set...